Skip to main content
. 2017 Jan 27;13(3):1911–1918. doi: 10.3892/ol.2017.5656

Figure 1.

Figure 1.

RECK promoter hypermethylation was observed in ESCC patients. (A) The mean MI of the RECK promoter in ESCC and corresponding non-tumor tissues. (B) The RECK MI showed a decreasing trend in non-tumor tissues compared with ESCC tissues. Statistical analyses were performed using the paired t-test. RECK, reversion-inducing cysteine-rich protein with kazal motif; MI, methylation index; ESCC, esophageal squamous cell carcinoma.